KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Chemistry / 2006 / Cilt: 30 - Sayı: 4

Synthesis and Biological Activities of N-Alkyl Derivatives of o-, m-, and p-Nitro (E)-4-Azachalcones and Stereoselective Photochemistry in Solution, with Theoretical Calculations

Synthesis and Biological Activities of N -Alkyl Derivatives of o-, m-, and p-Nitro (E)-4-Azachalcones and Stereoselective Photochemistry in Solution, with Theoretical Calculations

Nurettin YAYLI
Osman ÜÇÜNCÜ
Ahmet YAŞAR
Murat KÜÇÜK
Nuran YAYLI
Emine AKYÜZ
Şengül ALPAY KARAOĞLU
Sayfa
505–514
Yayın Tarihi
2006-04-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Experimental and theoretical calculations showed that d-truxinic type dimer is the most stable isomer.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The N-alkyl derivatisation and photochemical dimerisation of 3 o-, m-, and p-nitro substituted 4-azachalcones (1-3) yielded 3 new o-, m-, and p-nitro substituted (E)-N-decyl-4-azachalconium bromides, (2E)-1-(2-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)-2-propen-1-one (4), (2E)-1-(3-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)-2-propen- 1-one (5), and (2E)-1-(4-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)- 2-propen-1-one (6), and 3 new dimers in solution, (1b, 2a)-di- (3-nitrobenzoyl)-(3b, 4a)-di-(4-pyridinyl) cyclobutane (7), (1b, 2a)-di-(4-nitrobenzoyl)-(3b,4a)-di-(4-pyridinyl) cyclobutane (8a), and (1b, 2b)-di-(4-nitrobenzoyl)-(3b, 4a)-di-(4-pyridinyl)cyclobutane (8b), stereoselectively.
📊
Temel Bulgular & Veri:The monomers also showed high antioxidant activity, while the dimerisation products 7-8a,b were less active.
💡
Sonuç & Katkı:Experimental and theoretical calculations showed that d-truxinic type dimer is the most stable isomer.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Nitro-(E)-4-azachalcones · nitro-(E)-N-decyl-4-azachalconium bromide · photodimerisation

Özet

The N-alkyl derivatisation and photochemical dimerisation of 3 o-, m-, and p-nitro substituted 4-azachalcones (1-3) yielded 3 new o-, m-, and p-nitro substituted (E)-N-decyl-4-azachalconium bromides, (2E)-1-(2-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)-2-propen-1-one (4), (2E)-1-(3-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)-2-propen- 1-one (5), and (2E)-1-(4-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)- 2-propen-1-one (6), and 3 new dimers in solution, (1b, 2a)-di- (3-nitrobenzoyl)-(3b, 4a)-di-(4-pyridinyl) cyclobutane (7), (1b, 2a)-di-(4-nitrobenzoyl)-(3b,4a)-di-(4-pyridinyl) cyclobutane (8a), and (1b, 2b)-di-(4-nitrobenzoyl)-(3b, 4a)-di-(4-pyridinyl)cyclobutane (8b), stereoselectively. The monomeric compounds showed good antimicrobial activity against test micro-organisms. The most sensitive micro-organisms were Gram-positive bacteria. The monomers also showed high antioxidant activity, while the dimerisation products 7-8a,b were less active. Compound 6 was found to have similar or even higher activity when compared to the standard antioxidants TroloxR and vitamin C, respectively. The possible dimerisation products of compounds 1-3 were calculated theoretically. Experimental and theoretical calculations showed that d-truxinic type dimer is the most stable isomer.

Abstract

The N-alkyl derivatisation and photochemical dimerisation of 3 o-, m-, and p-nitro substituted 4-azachalcones (1-3) yielded 3 new o-, m-, and p-nitro substituted (E)-N-decyl-4-azachalconium bromides, (2E)-1-(2-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)-2-propen-1-one (4), (2E)-1-(3-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)-2-propen- 1-one (5), and (2E)-1-(4-nitrophenyl)-3-(N-decyl-4-pyridinium bromide)- 2-propen-1-one (6), and 3 new dimers in solution, (1b, 2a)-di- (3-nitrobenzoyl)-(3b, 4a)-di-(4-pyridinyl) cyclobutane (7), (1b, 2a)-di-(4-nitrobenzoyl)-(3b,4a)-di-(4-pyridinyl) cyclobutane (8a), and (1b, 2b)-di-(4-nitrobenzoyl)-(3b, 4a)-di-(4-pyridinyl)cyclobutane (8b), stereoselectively. The monomeric compounds showed good antimicrobial activity against test micro-organisms. The most sensitive micro-organisms were Gram-positive bacteria. The monomers also showed high antioxidant activity, while the dimerisation products 7-8a,b were less active. Compound 6 was found to have similar or even higher activity when compared to the standard antioxidants TroloxR and vitamin C, respectively. The possible dimerisation products of compounds 1-3 were calculated theoretically. Experimental and theoretical calculations showed that d-truxinic type dimer is the most stable isomer.

🔖

Bu Makaleye Atıf Yap

YAYLI, N., ÜÇÜNCÜ, O., YAŞAR, A., KÜÇÜK, M., YAYLI, N., AKYÜZ, E., KARAOĞLU, Ş. A. (2006). Synthesis and Biological Activities of N-Alkyl Derivatives of o-, m-, and p-Nitro (E)-4-Azachalcones and Stereoselective Photochemistry in Solution, with Theoretical Calculations. Turkish Journal of Chemistry, Cilt: 30 - Sayı: 4, 505–514. https://ajindex.com/articles/185414

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. J.B. Harborne, “The Flavonoids, Advances in Research”, Chapman & Hall, New York NY, 329-388, 1988.
  2. J.P.J. Marais, D. Ferreira and D. Slade, Phytochemistry 66, 2145-2176 (2005).
  3. Z. Nowakowska, E. Wyrzykiewicz and B. Kedzia, Il Farmaco 56, 325–329 (2001).
  4. M.L. Edwards, D.M. Stemarick, J.S. Sabol, K.A. Diekema and R.J. Dinerstein, J. Med. Chem. 37, 4357-4362 (1994). M. D’Auira and R. Racioppi, Tetrahedron 53, 17307-17316 (1997). M. D’Auria, L. Emanuele, V. Esposito and R. Racioppi, Arkivoc (xi), 65-78 (2002). M. D’Auria, Heterocycles, 54, 475-496 (2000). M. D’Auria, L. Emanuele, G. Mauriello and R. Racioppi, J. Photochem. Photobiol. A, 134, 147-154 (2000).
  5. N. Yaylı, A. Ya¸sar, O. ¨U¸c¨unc¨u, S. ¨O. Sivrikaya, C. G¨ule¸c, M. K¨u¸c¨uk and R. Abbasov, J. Photochem. Photobiol. A, 175, 291-298 (2005).
  6. N. Yaylı, O. ¨U¸c¨unc¨u, A. Ya¸sar, Y. G¨ok, M. K¨u¸c¨uk and S. Kolaylı, Tu rk. J. Chem., 28, 515-521 (2004).
  7. N. Yaylı, O. ¨U¸c¨unc¨u, E. Aydın, Y. G¨ok, A. Ya¸sar, C. Baltacı, N. Yıldırım and M. K¨u¸c¨uk, J. Photochem. Photobiol. A, 169, 229-234 (2005).
  8. V. Seidel, F. Bailleul and P.G. Waterman, Phytochemistry 55, 439-446 (2000).
  9. D.R. Katerere, A.I. Gray, A.R. Kennedy, R.J. Nash and R.D. Waigh, Phytochemistry 65, 433-438 (2004). M. D’Auria and R. Racioppi, J. Photochem. Photobiol. A, 112, 145-148 (1998).
  10. J. Durinda, L. Szucs, J. Kolena, A. Nagy, E. Misikova and J. Heger, Czech. Cesko-Slov. Farmac. 26, 140-149 (1977).
  11. V.L. Aeppli, K. Bernuuer, F. Schneider, K. Strub, W.E. Oberhansli and K.H. Pfoertner, Helv. Chim. Acta, 630-644 (1980).
  12. Z. Zhang, Y.W. Dong and G.W. Wang, Chem. Lett. 32, 966-967 (2003).
  13. Z. Nowakowska, E. Wyrzykiewicz and B. Kedzia, Il Farmaco 57, 657–661 (2002).
  14. Z. Nowakowska, Magn. Reson. Chem. 38, 382–383 (2000). B.Z. Jovanovi´c, M.M. Vukovi´c, A.D. Marinkovi´c and J. Csan´adi, J. Mol. Struct. 482-483, 371-374 (1999). National Committee for Clinical Laboratory Standard, NCCLS Document M7-A3, 13 (25), Willanova, PA., USA, 1993.
  15. M. Cuendet, K. Hostettmann and O. Potterat, Helv. Chim. Acta 80, 1144-1152 (1997).